BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260829T121849EDT-7279gVNMpa@132.216.98.100
DTSTAMP:20260829T161849Z
DESCRIPTION:Neoadjuvant Therapy for Operable Lung Cancer: Balancing Risks a
 nd Opportunities\n\nSpeaker: Jonathan Spicer\, MD\, PhD FRCS  \n\nAssociat
 e Professor\, Division of Thoracic Surgery\n	Director\, McGill Thoracic Onc
 ology Network\n	McGill University\, Montreal General Hospital\n\nEducationa
 l Objectives:  \n\n\n	Understand how to apply the latest data on precision 
 systemic therapy for patients with operable early-stage lung cancer\n	Expla
 in the place of new therapies for resectable disease within the broader co
 ntext of therapeutic  options\n	Describe important gaps in knowledge to bro
 aden the scope of efficacy of a neoadjuvant therapeutic strategy\n	Raise aw
 areness of risks involved of misguided use of peri-adjuvant precision ther
 apy\n\n\n\n	\n\nJoin the Medical Grand Rounds on Microsoft Teams meeting.\n
 	Or call in (audio only) NEW: +1 438-799-0762\, 502095193# Canada\, Montrea
 l\, Phone Conference ID: 502 095 193#\n\nThe Medical Grand Rounds are an a
 ccredited group learning activity as defined by the Maintenance of Certifi
 cation Program of the Royal College of Physicians and Surgeons of Canada.
 \n\nSome Rounds were video recorded.\n\nFull JGH Medical Grand Rounds Sche
 dule\n
DTSTART:20230327T163000Z
DTEND:20230327T173000Z
SUMMARY:Neoadjuvant Therapy for Operable Lung Cancer: Balancing Risks and O
 pportunities
URL:https://www.mcgill.ca/deptmedicine/channels/event/neoadjuvant-therapy-o
 perable-lung-cancer-balancing-risks-and-opportunities-346863
END:VEVENT
END:VCALENDAR